证券代码：301099 证券简称：雅创电子 公告编号：2026-007 上海雅创电子集团股份有限公司 关于收到深圳证券交易所《关于上海雅创电子集团股份有限 公司发行股份及支付现金购买资产并募集配套资金 申请向特定对象发行股票的审核问询函》的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 上海雅创电子集团股份有限公司（以下简称"公司"）于 2026 年 2 月 5 日收 到深圳证券交易所（以下简称"深交所"）出具的《关于上海雅创电子集团股份有 限公司发行股份及支付现金购买资产并募集配套资金申请的审核问询函》（审核 函〔2026〕030005 号）（以下简称"《审核问询函》"），根据《上市公司重大资 产重组管理办法》《深圳证券交易所上市公司重大资产重组审核规则》等有关规 定，深交所重组审核机构对公司发行股份及支付现金购买资产并募集配套资金申 请文件进行了审核，并形成了审核问询问题。 公司将根据《审核问询函》的要求，会同相关中介机构逐项落实并及时提交 对《审核问询函》的回复，回复内容将通过临时公告方式及时披露，同时在披露 后通过深交所并购重组审核业务系统报送相 ...

证券日报网讯1月29日，雅创电子（301099）在互动平台回答投资者提问时表示，参股公司类比半导体 的脑电客户主要以国内客户为主。 ...

证券日报网讯1月29日，雅创电子（301099）在互动平台回答投资者提问时表示，截至2026年1月20日， 公司股东户数超过2.1万户。 ...

格隆汇1月29日丨雅创电子(301099.SZ)在投资者互动平台表示，关于公司代理存储芯片的品牌包括南 亚、铠侠及国内品牌等。 ...

从资金流向上来看，当日其他电子板块主力资金净流出3.2亿元，游资资金净流出1.24亿元，散户资金净 流入4.44亿元。其他电子板块个股资金流向见下表： 证券之星消息，1月28日其他电子板块较上一交易日上涨0.01%，可立克领涨。当日上证指数报收于 4151.24，上涨0.27%。深证成指报收于14342.9，上涨0.09%。其他电子板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002782 | 可立克 | 23.33 | 6.43% | 31.65万 | 7.26亿 | | 300656 | 民德电子 | 27.64 | 6.14% | 21.62万 | 6.05亿 | | 300475 | 香农芯创 | 175.00 | 5.00% | 45.46万 | 77.80 乙 | | 002161 | 远望谷 | 8.81 | 2.68% | 64.94万 | 5.75亿 | | 300184 | 力源信息 | 11.15 | 2.29% | 82.65万 | 9.22亿 | ...

Group 1 - Tianqi Co., Ltd. has entered the brain-computer interface (BCI) sector by investing in Suzhou Huahui Chip, focusing on high-density flexible neural electrode technology, achieving animal testing stages, and becoming a key player in domestic BCI hardware localization. The developed flexible neural electrode has 1024 channels, with signal acquisition precision and anti-interference capabilities at an internationally advanced level. The company has also completed biocompatibility surface modification technology to reduce inflammation after electrode implantation, with core patents authorized by the National Intellectual Property Administration [1][2][3] - Innovation Medical, through its subsidiary Boling Brain Machine, is one of the first companies in China to commercialize BCI rehabilitation products. The core product, Cyberlink AC5, was officially launched in October 2025, generating sales revenue of 114,000 yuan in 2025. Another product, Cyberlink AM5, has completed multi-center clinical trials and is progressing through the approval process. The company plans to establish five additional clinical cooperation centers to accelerate the application of BCI technology in treating neurological diseases [4][5][6] - iFlytek is a leading company in the non-invasive BCI field, leveraging its artificial intelligence technology to develop BCI collaborative technology. The company has established long-term partnerships with universities for research and development. Its non-invasive BCI system has been piloted in 120 schools nationwide, improving student attention by 30%. In the medical field, a collaboration with Beijing Tiantan Hospital has achieved a 92% accuracy rate in identifying abnormal brain signals for epilepsy [7][8][9] Group 2 - Jiahe Intelligent focuses on the research and mass production of BCI hardware, particularly EEG acquisition devices and core components, serving both consumer and medical-grade markets. The company has achieved large-scale production of EEG acquisition headphones with a signal recognition accuracy of 92%, primarily used in sleep monitoring and attention training. It plans to expand into overseas BCI hardware markets by 2026 [10][11][12] - Tom Cat is the first company in China to apply BCI technology in consumer scenarios, focusing on interactive games and rehabilitation training products. The company launched a mind-controlled game product in 2025, which quickly gained over 500,000 users. It also collaborates with rehabilitation institutions to develop BCI rehabilitation training systems, showing a 35% average improvement in patient motor function scores [13][14][15] - Hanwei Technology, through its subsidiary Weisheng Technology, is a leading company in the EEG sensor field, with an annual shipment of over 2 million units. The company has developed an epilepsy early warning system with an 88% accuracy rate in clinical tests. It also focuses on flexible pressure sensors for invasive BCI electrodes, addressing industry pain points [16][17][18] Group 3 - StarNet Ruijie leverages its network communication technology to develop low-power, high-stability EEG signal transmission systems and data encryption modules, becoming a core supplier for BCI data links. The developed transmission system supports real-time transmission of 1024-channel EEG signals with a latency of less than 10ms and a stability of 99.9% [19][20][21] - Yijiahe focuses on the integration of BCI and embodied intelligent robots, exploring applications in smart healthcare. The company has signed a strategic cooperation agreement to develop real-time emotional companionship and brain-controlled robots, enhancing the emotional care capabilities of robots [22][23][24] - Lihua Technology is focused on incubating and investing in the BCI sector, successfully incubating three high-tech companies in the field. The company collaborates with the Shenzhen Institute of Advanced Technology to provide comprehensive services for incubated companies, addressing development pain points [25][26][27] Group 4 - Sanbo Neurosurgery is a leading private hospital in the neurosurgery field, focusing on the clinical application and research of BCI. The company has successfully conducted an interventional BCI surgery, accumulating valuable experience for clinical applications. It is also recruiting participants for ongoing clinical trials [28][29][30] - Shiyun Circuit is a core enterprise in the PCB field, providing customized PCB products for BCI devices. The company focuses on high-density, flexible PCB designs, achieving low signal loss rates below 2% [31][32][33] - Meihua Medical is a leading supplier of core components for BCI, having entered the core supply chain for invasive BCI products. The company has developed components that have passed biocompatibility tests, ensuring long-term stability and safety for implanted devices [34][35][36]

（文章来源：证券日报） 证券日报网讯 1月26日，雅创电子在互动平台回答投资者提问时表示，截至2026年1月10日，公司股东 户数超过2.3万户。 ...

雅创电子公告，公司拟发行股份及支付现金购买深圳欧创芯半导体有限公司40.00%股权以及深圳市怡 海能达有限公司45.00%股权并募集配套资金的申请文件已获得深圳证券交易所受理。本次交易尚需履 行多项审批程序，包括深交所审核通过、中国证券监督管理委员会同意注册等，能否获得批准及时间存 在不确定性。 ...

证券代码：301099 证券简称：雅创电子 公告编号：2026-006 上海雅创电子集团股份有限公司 公司于 2026 年 1 月 23 日收到深圳证券交易所（以下简称"深交所"）出具 的《关于受理上海雅创电子集团股份有限公司发行股份购买资产并募集配套资金 申请文件的通知》（深证上审〔2026〕17 号）。根据《上市公司重大资产重组 管理办法》《深圳证券交易所上市公司重大资产重组审核规则》等相关规定，深 交所对公司报送的发行股份及支付现金购买资产并募集配套资金申请文件进行 了核对，认为申请文件齐备，决定予以受理。 本次交易尚需履行多项审批程序方可实施，包括但不限于深交所审核通过、 中国证券监督管理委员会同意注册等。本次交易能否获得上述相关部门的批准， 以及最终获得批准的时间均存在不确定性。 公司将根据本次交易事项的进展情况，严格按照相关法律法规、规范性文件 的要求及时履行信息披露义务，公司所有信息均以在指定媒体刊登的信息为准。 敬请广大投资者关注公司后续公告并注意投资风险。 关于发行股份及支付现金购买资产并募集配套资金 的申请文件获得深圳证券交易所受理的公告 本公司及董事会全体成员保证信息披露的内容真实、准确 ...

Group 1 - The core viewpoint of the news is that 雅创电子 (Yachuang Electronics) has shown significant fluctuations in its stock performance and financial metrics, indicating both growth in revenue and challenges in net profit [1][2]. - On January 22, 雅创电子's stock rose by 3.33%, with a trading volume of 377 million yuan. The financing data shows a net financing outflow of 7.76 million yuan for the day, with a total financing and securities balance of 319 million yuan [1]. - The financing balance of 雅创电子 is 318 million yuan, accounting for 4.32% of its market capitalization, which is above the 90th percentile level over the past year, indicating a high level of financing activity [1]. Group 2 - As of December 31, 雅创电子 had 20,000 shareholders, an increase of 5.26% from the previous period, while the average circulating shares per person decreased by 5.00% to 4,489 shares [2]. - For the period from January to September 2025, 雅创电子 reported a revenue of 4.655 billion yuan, representing a year-on-year growth of 105.27%. However, the net profit attributable to shareholders decreased by 19.29% to 82.77 million yuan [2]. - 雅创电子 has distributed a total of 102 million yuan in dividends since its A-share listing, with 78.05 million yuan distributed over the past three years [3].